Marathon Trading Investment Management’s GoPro GPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-24,284
Closed -$110K 361
2020
Q3
$110K Buy
24,284
+4,600
+23% +$21.6K 0.01% 251
2020
Q2
$94K Sell
19,684
-1,966
-9% -$7.46K 0.01% 168
2020
Q1
$57K Buy
21,650
+10,100
+87% +$37.5K 0.01% 135
2019
Q4
$50K Sell
11,550
-1,700
-13% -$7.05K ﹤0.01% 185
2019
Q3
$69K Buy
+13,250
New +$62.2K 0.01% 179
2019
Q1
Sell
-40,000
Closed -$170K 254
2018
Q4
$170K Buy
+40,000
New +$224K 0.01% 219
2017
Q4
Sell
-15,300
Closed -$168K 183
2017
Q3
$168K Sell
15,300
-2,100
-12% -$19.7K 0.02% 135
2017
Q2
$141K Buy
+17,400
New +$147K 0.03% 133
2016
Q2
Sell
-10,000
Closed -$120K 139
2016
Q1
$120K Buy
+10,000
New +$124K 0.02% 132
2015
Q3
Sell
-6,138
Closed -$302K 360
2015
Q2
$324K Buy
+6,138
New +$315K 0.01% 370
2015
Q1
Sell
-12,210
Closed -$576K 528
2014
Q4
$772K Sell
12,210
-173,740
-93% -$12.8M 0.01% 360
2014
Q3
$17.4M Buy
+185,950
New +$9.5M 0.48% 30

Other funds holding GPRO

Marathon Trading Investment Management's GPRO Position: Q4 2020 in Review

Marathon Trading Investment Management sold out of GoPro (GPRO) in Q4 2020, closing a stake of 24,284 shares — an estimated $110K sold.

Marathon Trading Investment Management first reported a position in GPRO in Q3 2014 and held it in 12 quarters. The position peaked at $17.4M in Q3 2014. 205 funds tracked by Wall St. Rank hold GPRO as of Q4 2020.

  • Marathon Trading Investment Management reported no remaining GoPro position as of Q4 2020 after selling out during the quarter.
  • Marathon Trading Investment Management sold 24,284 GoPro shares in Q4 2020, an estimated $110K.
  • Marathon Trading Investment Management first reported a position in GoPro in Q3 2014 and held it in 12 quarters.
  • Marathon Trading Investment Management's GoPro position peaked at $17.4M in Q3 2014.
  • 205 funds tracked by Wall St. Rank held GoPro as of Q4 2020.

Based on Marathon Trading Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.